- Neocleous A, Nicolaides K, Schizas C. Intelligent Non-invasive Diagnosis of Aneuploidy: Raw Values and Highly Imbalanced Dataset. IEEE J Biomed Health Inform DOI: 10.1109/JBHI.2016.2608859 pdf
- Neocleous AC, Nicolaides KH, Schizas CN. First Trimester Noninvasive Prenatal Diagnosis: A Computational Intelligence Approach. IEEE J Biomed Health Inform 2016;20:1427-38 pdf
- Kagan KO, Wright D, Nicolaides KH. First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2015;45:42-7 pdf
- Wright D, Syngelaki A, Bradbury I, Akolekar R, Nicolaides KH. First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing. Fetal Diagn Ther 2014;35:118-26 pdf
- Persico N, Fabietti I, Baffero G, Fedele L, Nicolaides KH. Fetal right ventricular contraction and relaxation times at 11-13 weeks' gestation by speckle tracking imaging. Ultrasound Obstet Gynecol 2014;43:284-90 pdf
- Nicolaides KH, Wright D, Poon LC, Syngelaki A, Gil MM. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2013;42:41-50 pdf
- Nicolaides KH, Syngelaki A, Poon LC, Gil M, Wright D. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing. Fetal Diagn Ther 2014;35:185-92 pdf
- Sonek JD, Nicolaides KH, Janku P. Screening at 11-13+6 weeks' gestation. Ceska Gynekol 2012;77:92-104
- Maiz N, Wright D, Ferreira AF, Syngelaki A, Nicolaides KH. A mixture model of ductus venosus pulsatility index in screening for aneuploidies at 11-13 weeks' gestation. Fetal Diagn Ther 2012;31:221-9 pdf
- Turan OM, Turan S, Berg C, Gembruch U, Nicolaides KH, Harman CR, Baschat AA. The duration of persistent abnormal ductus venosus flow and its impact on perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol 2011;38:295-302 pdf
- Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:7-15 pdf
- Staboulidou I, Pereira S, Cruz JJ, Syngelaki A, Nicolaides KH. Prevalence and Outcome of Absence of Ductus Venosus at 11 to 13(+6) Weeks. Fetal Diagn Ther 2011;30:35-40 pdf
- Matias A, Maiz N, Montenegro N, Nicolaides K. Ductus venosus flow at 11-13 weeks in the prediction of birth weight discordance in monochorionic twins. J Perinat Med 2011;39:467-70
- Chelemen T, Syngelaki A, Maiz N, Allan L, Nicolaides KH. Contribution of ductus venosus doppler in first-trimester screening for major cardiac defects. Fetal Diagn Ther 2011;29:127-34 pdf
- Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment. Prenat Diagn 2011;31:3-6 pdf
- Maiz N, Nicolaides KH. Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications. Fetal Diagn Ther 2010;28:65-71 pdf
- Sonek J, Nicolaides K. Additional first-trimester ultrasound markers. Clin Lab Med 2010;30:573-92
- Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009;33:512-7 pdf
- Maiz N, Staboulidou I, Leal AM, Minekawa R, Nicolaides KH. Ductus venosus Doppler at 11 to 13 weeks of gestation in the prediction of outcome in twin pregnancies. Obstet Gynecol 2009;113:860-5
- Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation. Obstet Gynecol 2008;112:598-605